Skip to main content
TipRanks
Go Ultimate75% OFF

Recordati Industria Chimica e Farmaceutica SPA (0KBS) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Recordati Industria Chimica e Farmaceutica SPA has a market cap or net worth of EUR 10.89B. The enterprise value is EUR 12.70B.

Market Cap
EUR 10.89B
Enterprise Value
EUR 12.70B

Share Statistics

Recordati Industria Chimica e Farmaceutica SPA has 209,125,150 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
209,125,150
Owned by Insiders
0.08%
Owned by Institutions
8.62%

Financial Efficiency

Recordati Industria Chimica e Farmaceutica SPA’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 12.11%.

Return on Equity (ROE)
0.23
Return on Assets (ROA)
0.08
Return on Invested Capital (ROIC)
12.11%
Return on Capital Employed (ROCE)
0.17
Revenue Per Employee
557.93K
Profits Per Employee
94.53K
Employee Count
4,693
Asset Turnover
0.50
Inventory Turnover
1.54

Valuation Ratios

The current PE Ratio of Recordati Industria Chimica e Farmaceutica SPA is 20.69. Recordati Industria Chimica e Farmaceutica SPA’s PEG ratio is 0.70.

PE Ratio
20.69
PS Ratio
3.94
PB Ratio
4.71
Price to FCF
18.00
Price to Operating Cash Flow
16.68
PEG Ratio
0.70

Income Statement

In the last 12 months, Recordati Industria Chimica e Farmaceutica SPA had revenue of 2.62B and earned 443.62M in profits. Earnings per share was 2.16.

Revenue
2.62B
Gross Profit
1.79B
Operating Income
719.74M
Pretax Income
581.27M
Net Income
443.62M
EBITDA
887.00M
Earnings Per Share (EPS)
2.16

Cash Flow

In the last 12 months, operating cash flow was 660.61M and capital expenditures -55.93M, giving a free cash flow of 604.68M billion.

Operating Cash Flow
660.61M
Free Cash Flow
604.68M
Free Cash Flow per Share
2.90

Dividends & Yields

Recordati Industria Chimica e Farmaceutica SPA pays an annual dividend of ―, resulting in a dividend yield of 2.54%

Dividend Per Share
―
Dividend Yield
2.54%
Payout Ratio
N/A
Free Cash Flow Yield
5.55%
Earnings Yield
4.76%

Stock Price Statistics

Beta
0.67
52-Week Price Change
1.93%
50-Day Moving Average
52.84
200-Day Moving Average
50.61
Relative Strength Index (RSI)
48.90
Average Volume (3m)
90.53K

Important Dates

Recordati Industria Chimica e Farmaceutica SPA upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 10, 2026
Next Earnings Date
Feb 25, 2027
Ex-Dividend Date
―

Financial Position

Recordati Industria Chimica e Farmaceutica SPA as a current ratio of 1.59, with Debt / Equity ratio of 128.53%

Current Ratio
1.59
Quick Ratio
1.08
Debt to Market Cap
0.24
Net Debt to EBITDA
2.30
Interest Coverage Ratio
7.25

Taxes

In the past 12 months, Recordati Industria Chimica e Farmaceutica SPA has paid 137.65M in taxes.

Income Tax
137.65M
Effective Tax Rate
0.24

Enterprise Valuation

Recordati Industria Chimica e Farmaceutica SPA EV to EBITDA ratio is 12.36, with an EV/FCF ratio of 20.82.

EV to Sales
4.55
EV to EBITDA
12.36
EV to Free Cash Flow
20.82
EV to Operating Cash Flow
19.06

Balance Sheet

Recordati Industria Chimica e Farmaceutica SPA has EUR 503.26M in cash and marketable securities with EUR 2.21B in debt, giving a net cash position of -EUR 1.70B billion.

Cash & Marketable Securities
EUR 503.26M
Total Debt
EUR 2.21B
Net Cash
-EUR 1.70B
Net Cash Per Share
-EUR 8.15
Tangible Book Value Per Share
-EUR 3.90

Margins

Gross margin is 71.38%, with operating margin of 31.11%, and net profit margin of 18.96%.

Gross Margin
71.38%
Operating Margin
31.11%
Pretax Margin
24.94%
Net Profit Margin
18.96%
EBITDA Margin
36.82%
EBIT Margin
28.89%

Analyst Forecast

The average price target for Recordati Industria Chimica e Farmaceutica SPA is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
8.27%
EPS Growth Forecast
30.25%